Phase 2 RCT | Lysergic acid diethylamide–assisted therapy in patients with anxiety with and without a life-threatening illness 2 Feb, 2023 | 14:45h | UTC Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study – Biological Psychiatry Commentary: LSD-assisted therapy induces rapid and lasting reductions in anxiety and depression symptoms, according to new research – PsyPost